Tag Archives: History

Senator Orrin Hatch needs to be named in opioid lawsuits filed nationwide!

Senator Hatch receives the American Pain Foundation's Public Service Award from Dr. Perry Fine, Professor of Anesthesiology, University of Utah. (Undated photo on Hatch's website)

Senator Hatch receives the American Pain Foundation’s Public Service Award from Dr. Perry Fine, Professor of Anesthesiology, University of Utah. (Undated photo on Hatch’s website)

This past week U.S. Senator Orrin Hatch (Utah) announced his retirement from the Senate at 83 years old.

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH) Before Mr. Hatch attends his retirement party as Chairman of the U.S. Senate Finance Committee, maybe some vital matters should be addressed.  Hatch was a member of the U.S. Senate Finance Committee in 2012 when an investigation into the prescription opioid epidemic was launched naming several pharmaceutical companies as well as The American Pain Foundation, The American Academy of Pain Medicine and The American Pain Society, as well as several physicians.  Two of the physicians named in the investigation were Perry Fine, MD and Lynn Webster, MD both from Utah.  I am calling for Hatch to be charged with obstruction of justice and named as a defendant in the many lawsuits filed throughout the country against pharmaceutical companies such as Purdue Pharma, maker of OxyContin.  My call for Orrin Hatch to be brought into legal action is based on the following information as regards the investigation into the prescription opioid epidemic addicting and killing in the tens of thousands:

Lynn R. Webster, MD sets standard for DEA investigations

Lynn Webster

Lynn Webster

Following the trail of the prescription opioid epidemic and the DEA’s efforts to expose the purveyors.

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH) In 2013, the Drug Enforcement Administration (DEA) launched an investigation of then-president-elect of the American Academy of Pain Medicine (AAPM) Lynn R. Webster, MD, related to overdose deaths at Webster’s Lifetree Pain Clinic in Salt Lake City. It was alleged there were up to 100 deaths at Webster’s clinic which was raided by the DEA.  Webster attributed the deaths to “suicide” and the pain clinic closed its doors.  The U.S. Attorney for the District of Utah declined to pursue charges, effectively ending the DEA investigation.  US Senator Orrin Hatch (Utah) was rumored to be the force behind charges being dropped against Webster.

Gov. Christie’s Opioid Commission and the Nation’s Biggest Nightmare – J. David Haddox, MD, DDS

CaptureHow many lives could have been saved?

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH)  This should scare anyone involved in the prescription opioid/heroin epidemic. J. David Haddox, MD, DDS is the “gate keeper” at Purdue Pharma and successfully downplayed the dangers of OxyContin in the late 1990’s. Haddox “coined” a word “pseudo-addiction” without scientific data.  The definition of Haddox’s word “pseudo-addiction” is A drug-seeking behavior that simulates true addiction, which occurs in patients with pain who are receiving inadequate pain medication. So Haddox’s message to the medical profession was “more” is appropriate when treating patients with dangerous narcotics — and the medical profession bought it. In the meantime, Haddox’s employer, Purdue Pharma made billions of dollars in the sale of their drug OxyContin — as lives were ended.

Purdue Pharma has another “killer” surprise for America — addicting 7 to 16 year olds!

butransThere is little outrage from the public in Purdue Pharma targeting children as young as 7 years old with yet another Holocaust of death in an FDA approved opioid.

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH)  On September 14, the FDA Advisory Committee will be holding a hearing on Purdue Pharma’s new “blockbuster” opioid called Butrans.  It is targeted for severe pain in children ages 7 to 16 years old.  There is not a doubt in my mind that once the FDA approves this latest killer opioid presented by Purdue Pharma, it will be off-labeled marketed as OxyContin was for all pain levels.  This time though children are the guinea pigs and Purdue Pharma and its owners, the Sacklers will in all probability double their profits.

President Trump nominating Rep. Tom Marino, PA (again) for “drug czar” is a disservice to America!

Rep. Tom Marino

Rep. Tom Marino

Hopefully Mr. Trump will not allow the “alligator” with financial ties to the pharmaceutical industry to become “drug czar” while Marino thumbs his nose at the DEA and the families suffering the loss of loved ones to an out of control prescription opioid/heroin epidemic.

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH)  President Donald Trump announced that he intends to nominate Rep. Tom Marino (R) of Pennsylvania to head the Office of National Drug Control Policy — second time for nomination.  Marino has been a longtime supporter of the president — so much so that Trump nominated Marino back in the spring for the same position — drug czar.  Marino withdrew his name in May because of “family issues.”

Web Design BangladeshBangladesh Online Market